Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 6241 of 6351
-
Liver study checks drug safety in 24 volunteers
Knowledge-focused CompletedThis was a multicentric, open-label, non-randomized study to evaluate the pharmacokinetic, safety and tolerability of ITF2357 in participants with chronic hepatic impairment relative to matched participants with normal hepatic function.
Phase 1 • Sponsor: Italfarmaco • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Healthy volunteers test new drug interactions
Knowledge-focused CompletedThe purpose of this study is to assess the impact of multiple doses of itraconazole on the pharmacokinetics (PK) of AZD5004 in healthy participants (Part A), and to assess the impact of multiple doses of AZD5004 on the PK of Combined Oral Contraceptives (COCs) in healthy female p…
Phase 1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Crush or swallow? new study tests best way to take diabetes drug empagliflozin
Knowledge-focused CompletedThis trial is conducted to test how empagliflozin is taken up in the body when taken as a whole tablet or dissolved in water and mixed with food.
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:06 UTC
-
New drug LY3867070 put to the test in healthy humans
Knowledge-focused Recruiting nowThe purpose of this study is to evaluate how well LY3867070 is tolerated and what side effects may occur in healthy participants. The study drug will be administered orally. Blood tests will be performed to investigate how the body processes the study drug and how the study drug …
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Breakfast or not? study tests Food's impact on new drug formulation
Knowledge-focused CompletedThis is a phase I, single-center, randomized, open-label, single-dose, 2-way, 2-period, crossover study to evaluate the effect of food on the pharmacokinetics (PK) of vamifeport prolonged-release (PR) formulation in healthy adult participants. Participants will be randomly alloca…
Phase 1 • Sponsor: CSL Behring • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
New drug KINE-101 put to the test in healthy volunteers
Knowledge-focused CompletedThis is a randomized, single-center, single-blind, placebo-controlled, dose-escalation Phase 1 clinical trial designed to evaluate the safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of multiple intravenous (IV) infusions of KINE-101 in healthy adult vo…
Phase 1 • Sponsor: Kine Sciences Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Online course boosts ICU Nurses' conflict skills
Knowledge-focused CompletedThis study will be conducted in a randomized parallel controlled experimental study design to determine the effect of web-based conflict resolution training to be applied to intensive care nurses on the conflict resolution skills of nurses. The study will be conducted with 46 nu…
Sponsor: Gazi University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Anesthesiologists surveyed on diversity education
Knowledge-focused CompletedTo date, there has not been an assessment of ASA members to determine satisfaction with DEI and cultural humility/structural competency education within institutions and programs. We developed a 24-question survey that will be distributed via email to current members of the Ameri…
Sponsor: Hospital for Special Surgery, New York • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
New drug PG-033 enters first human safety tests
Knowledge-focused Recruiting nowThe goal of this study is to evaluate the safety, tolerability and pharmacokinetics (PK) profiles of single ascending oral doses(SAD) of PG-033 by directly comparing it with placebo. Meanwhile, the impact of a high-fat meal on the pharmacokinetics of PG-033 will also be evaluated…
Phase 1 • Sponsor: Prime Gene Therapeutics Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Generic cholesterol drug shows promise in early comparison
Knowledge-focused CompletedSingle dose oral bioequivalence study of Bempedoic Acid 180 mg Film Coated Tablet and Nilemdo® (Bempedoic Acid) 180 mg Film-coated tablets in healthy adult human subjects under fasting conditions.
Phase 1 • Sponsor: Humanis Saglık Anonim Sirketi • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:45 UTC
-
Cancer drug interaction study halted after just one patient
Knowledge-focused Stopped earlyThe study aims to assess the effect of ceralasertib on the pharmacokinetics (PK) of Drug X, Drug Y and Drug Z in participants with advanced solid tumours.
Phase 1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
Healthy volunteers help test how food and acid pills change drug absorption
Knowledge-focused CompletedThe purpose of this study is to evaluate the safety and effect of food on LY4064809 and the safety and effect of stomach changes by a proton pump inhibitor (PPI) esomeprazole, under fasted conditions in healthy adult participants. Blood tests will be performed to investigate how …
Phase 1 • Sponsor: Scorpion Therapeutics, a wholly owned subsidiary of Eli Lilly and Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Could a new whey drink beat water for hydration in kids?
Knowledge-focused CompletedThe main aim of this clinical trial is to compare the beverage hydration index of three different beverages in primary school-aged children.The Beverage Hydration Index (BHI), compares the hydration value of beverages against water. This study will explore the fluid retention cap…
Sponsor: Northumbria University • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:11 UTC
-
Healthy volunteers help test new drug NAV-240 for first time in humans
Knowledge-focused CompletedThe goal of this clinical trial is to assess initial safety/tolerability of multiple doses of drug NAV-240. It will also learn about the profile and immunogenicity of drug NAV-240. The main question it aims to answer is: • What medical problems do participants have when taking m…
Phase 1 • Sponsor: Navigator Medicines, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Do masks mess with MRI? small study checks image quality
Knowledge-focused CompletedIn radiotherapy, CT scans are the reference imaging tool for treatment planning, as they provide the electron density of the tissues required to calculate the dose. Magnetic Resonance Imaging (MRI) is used as a complement to CT to contour target volumes and organs at risk. While …
Sponsor: Institut Cancerologie de l'Ouest • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
NASA tests if simulator movement helps pilots fly better with Mixed-Reality goggles
Knowledge-focused CompletedThe purpose of this research is to investigate how different levels of simulator motion fidelity affect pilot performance in two different flight tasks while using a head mounted display (or mixed-reality headset) for out-the-window (OTW) visuals. Three levels of motion fidelity …
Sponsor: National Aeronautics and Space Administration (NASA) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
New drug ORKA-002 tested in humans for the first time
Knowledge-focused OngoingThis is a Phase 1, first-in-human study to evaluate the safety, tolerability, and pharmacokinetics of ORKA-002 in healthy participants.
Phase 1 • Sponsor: Oruka Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
New injection Y-3 put to the test: will it clash with common drugs?
Knowledge-focused CompletedThe primary goal of this clinical trial is to evaluate the effect of Y-3 for injection on the pharmacokinetic profile of the sensitive finger substrates repaglinide tablets, warfarin sodium tablets, and omeprazole enteric-coated capsules for CYP2C8, CYP2C9, and CYP2C19 in Chinese…
Phase 1 • Sponsor: Neurodawn Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Tooth filling showdown: can new materials stop Post-Drill pain?
Symptom relief Recruiting nowThe aim of this study is to evaluate the effect of flowable conventional and bulk-fill composites on postoperative sensitivity in class I cavities over long-term follow-up. The hypothesis to be tested in this study is that the type of composite material will not affect clinical s…
Sponsor: Recep Tayyip Erdogan University • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Healthy women help compare two versions of sotatercept
Knowledge-focused CompletedThe goal of the study is to learn what happens to different forms of sotatercept medications in a healthy person's body over time. Researchers want to know if there is a difference in the healthy person's body when different forms of sotatercept medications are given.
Phase 1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC